Marshall Islands vs Myanmar: Immunization, Hib3
Marshall Islands
72.0%
in 2024
Myanmar
71.0%
in 2024
Marshall Islands rank
160th
Myanmar rank
162nd
Immunization, Hib3 over time
- Marshall Islands
- Myanmar
How they compare
Marshall Islands currently reports 72.0% against 71.0% in Myanmar, a difference of 1.0%.
The two have swapped places 3 times across 12 shared years of data; in 2013 it was Myanmar ahead.
Marshall Islands ranks 160th and Myanmar ranks 162nd of 191 countries.
Across the 2 decades both report, Marshall Islands averaged higher in 1 and Myanmar in 1.
Head to head by decade
| Decade | Marshall Islands | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.9% | 87.4% | 20.6% | Myanmar |
| 2020s | 71.8% | 66.8% | 5.0% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Marshall Islands or Myanmar?
- Marshall Islands, at 72.0% against 71.0% in Myanmar as of 2024.
- What is the difference in immunization, hib3 between Marshall Islands and Myanmar?
- 1.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Myanmar?
- 12 years are reported by both, from 2013 to 2024.
- How do Marshall Islands and Myanmar rank globally for immunization, hib3?
- Marshall Islands ranks 160th and Myanmar ranks 162nd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.